Latest Seizure Stories

LOS ANGELES, April 2, 2012 /PRNewswire/ -- NeuroSigma, Inc., a Los Angeles-based medical device company, today announced its appointment of Christopher M. DeGiorgio, M.D., as Vice-President, Neurology. In this new role Dr. DeGiorgio, who was previously a Senior Medical Advisor to the Company, will lead NeuroSigma's development of Trigeminal Nerve Stimulation (TNS) for the treatment of neurological indications. "I am very excited to join NeuroSigma to help move TNS therapy forward...

Long-awaited Institute of Medicine Committee Report will address the broader spectrum of issues affecting those living with epilepsy Los Angeles, CA and Washington D.C. (PRWEB) March 30, 2012 The Institute of Medicine Committee on The Public Health Dimension of the Epilepsies recently completed a 20-month long study and will be releasing its results in a report entitled “Epilepsy Across the Spectrum: Promoting Health and Understanding.” The Committee will travel to Washington D.C. to...

A portion of the grant funding raised at the local Foundation's annual Care and Cure Benefit will support UCSF postdoctoral fellow Jiadong Chen’s clinical training and research to aid in the effort to care and cure pediatric epilepsy. Los Angeles, CA (PRWEB) March 30, 2012 The Epilepsy Foundation of Greater Los Angeles awarded a $50,000 “Care and Cure” grant to the University of California, San Francisco to support the postdoctoral training and work of Jiadong Chen, Ph.D. The...

WASHINGTON, March 28, 2012 /PRNewswire/ -- For the more than three million Americans who live with epilepsy, gaining seizure control is a top priority. Representatives from UCB and the Epilepsy Advocate program will travel to Washington, D.C. for the Epilepsy Foundation's National Walk for Epilepsy, shining a spotlight on the condition and demonstrating that seizure control and living beyond the boundaries of epilepsy are possible. As part of a new project known as "My Four Words,"...

Early-initiated immunotherapy appears to be associated with improved seizure outcomes among patients with autoimmune epilepsy, according to a report published Online First by Archives of Neurology, one of the JAMA/Archives journals. "Antiepileptic drugs (AEDs) are the mainstay of treatment for epilepsy, but seizures continue in one-third of patients despite appropriate AED therapeutic trials," the authors write as background in the study. "Even in the current era, the etiology of epilepsy...

A new epilepsy gene for idiopathic epilepsy in Belgian Shepherds has been found in the canine chromosome 37. The research of Professor Hannes Lohi and his group conducted at the University of Helsinki and the Folkhälsan Research Center opens new avenues for the understanding of the genetic background of the most common canine epilepsies. The research also has an impact on the understanding of common epilepsies in humans. The research is published in the scientific journal PLoS ONE on March...

Drug manufacturer deviates from appropriate comparator therapy specified by the G-BA The drug retigabine (trade name: Trobalt®) was approved in March 2011 as add-on therapy for adults with epileptic seizures. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products” (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether retigabine offers an added benefit compared with the present standard therapy....

MINNEAPOLIS and GENEVA, March 16, 2012 /PRNewswire/ -- Milestone comes 25 years after the first DBS implant for Tremor carried out in Grenoble, France Medtronic, Inc. (NYSE: MDT) today announced that a patient from Kempenhaeghe-Heeze (The Netherlands) is the first patient to be enrolled into the MORE (MedtrOnic Registry for Epilepsy) Registry which is designed to look at the long-term efficacy, quality of life impact and safety of deep brain stimulation (DBS) in...

Most patients wait until it's too late to prevent serious disability While the thought of any type of surgery can be disconcerting, the thought of brain surgery can be downright frightening. But for people with a particular form of epilepsy, surgical intervention can literally be life-restoring. Yet among people who suffer from what's known as medically intractable epilepsy, in which seizures are resistant to drugs, only a small fraction will seek surgery, seeing it only as a last...